iconEarnings Announcement Before Market Open

DURECT Corp DRRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
1.03quote price arrow down-0.13 (-11.21%)
Volume
1,807
Close
1.16UNCH (UNCH)
Volume
171,586
52 week range
0.47 - 7.46
Loading...
  • Open1.02
  • Day High1.19
  • Day Low0.97
  • Prev Close1.16
  • 52 Week High7.46
  • 52 Week High Date05/22/23
  • 52 Week Low0.47
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap36.002M
  • Shares Out31.04M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.96
  • YTD % Change96.61

KEY STATS

  • Open1.02
  • Day High1.19
  • Day Low0.97
  • Prev Close1.16
  • 52 Week High7.46
  • 52 Week High Date05/22/23
  • 52 Week Low0.47
  • 52 Week Low Date11/10/23
  • Market Cap36.002M
  • Shares Out31.04M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.96
  • YTD % Change96.61

RATIOS/PROFITABILITY

  • EPS (TTM)-1.12
  • P/E (TTM)-1.04
  • Fwd P/E (NTM)-1.28
  • EBITDA (TTM)-36.853M
  • ROE (TTM)-138.93%
  • Revenue (TTM)8.548M
  • Gross Margin (TTM)79.91%
  • Net Margin (TTM)-323.16%
  • Debt To Equity (MRQ)112.72%

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On DURECT Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
DURECT Corporation is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol is in clinical development for the potential treatment of alcohol-associated hepatitis, for which United States Food and Drug Administration (FDA) has granted a Fast Track...
Gail Maderis
Independent Chairman of the Board
James Brown
President, Chief Executive Officer, Director
Timothy Papp
Chief Financial Officer, Company Secretary
Address
10240 Bubb Road
Cupertino, CA
95014
United States

Top Peers

SYMBOLLASTCHG%CHG
SEEL
Seelos Therapeutics Inc
0.3393UNCHUNCH
CYTH
Cyclo Therapeutics Inc
1.51UNCHUNCH
VYNE
Vyne Therapeutics Inc
2.62UNCHUNCH
AVTX
Avalo Therapeutics Inc
14.36UNCHUNCH
TLPH
Talphera Inc
1.02UNCHUNCH